Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer
October 17, 2011 06:00 ET
|
Acura Pharmaceuticals
PALATINE, IL--(Marketwire - Oct 17, 2011) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company, announced that they have been informed by Pfizer, Inc. (NYSE: PFE) that...